A HIf1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

PLoS Genetics

Volumn 1, Issue 1, 2005, Pages 0072-0080

  Dahia, Patricia L M ^a   Ross, Ken N ^b   Wright, Matthew E ^a   Hayashida, César Y ^c   Santagata, Sandro ^d   Barontini, Marta ^e   Kung, Andrew L ^a   Sanso, Gabriela ^e   Powers, James F ^f   Tischler, Arthur S ^f   Hodin, Richard ^g   Heitritter, Shannon ^d   Moore Jr , Francis ^d   Dluhy, Robert ^d   Sosa, Julie Ann ^h   Ocal, I Tolgay ^h   Benn, Diana E ⁱ   Marsh, Deborah J ⁱ   Robinson, Bruce G ⁱ   Schneider, Katherine ^a   Garber, Judy ^a   Arum, Seth M ^j   Korbonits, Márta ^k   Grossman, Ashley ^k   Pigny, Pascal ^l   Toledo, Sérgio P A ^c   Nose, Vania ^d   Li, Cheng ^a   Stiles, Charles D ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^f TUFTS MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h YALE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j BOSTON MEDICAL CENTER   (United States)

^k ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^l LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955594623     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0010008     Document Type: Article

References (43)

1. Manger WM, Gifford RW (2002) Pheochromocytoma. J Clin Hypertens (Greenwich) 4: 62-72.
2. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL (2003) Pheochromocytoma: The expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196-1204.
3. Kaelin WG Jr (2003) The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14: 2703-2711.
4. Kondo K, Kim WY, Lechpammer M, Kaelin WG Jr (2003) Inhibition of HIF2a is sufficient to suppress pVHL-defective tumor growth. PLoS Biol 1: e83. DOI: 10.1371/journal.pbio.0020289.
5. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr (2002) Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1: 237-246.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851.
7. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49-54.
8. Ackrell BA (2000) Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett 466: 1-5.
9. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, et al. (2001) The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 69: 1186-1197.
10. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/ or malignant phaeochromocytomas. Cancer Res 63: 5615-5621.
11. Kaelin WG Jr (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2: 673-682.
12. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, et al. (2001) Von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10: 1019-1027.
13. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, et al. (2001) Contrasting effects on HIF-1a regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 10: 1029-1038.
14. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, et al. (2002) Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab 87: 4771-4774.
15. Yankovskaya V, Horsefield R, Tornroth S, Luna-Chavez C, Miyoshi H, et al. (2003) Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299: 700-704.
16. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, et al. (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63: 851-859.
17. Califano D, Rizzo C, D'Alessio A, Colucci-D'Amato GL, Cali G, et al. (2000) Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells. J Biol Chem 275: 19297-19305.
18. Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, et al. (2003) Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 12: 889-901.
19. Selak MA, Armour SM, Mackenzie ED, Boulahbel H, Watson DG, et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIFa prolyl hydroxylase. Cancer Cell 7: 77-85.
20. Ivan M, Kondo K, Yang H, Kim W, Valiando J, et al. (2001) HIFa targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468.
21. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, et al. (2001) Targeting of HIFa to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472.
22. Ishii T, Yasuda K, Akatsuka A, Hino O, Hartman PS, et al. (2005) A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res 65: 203-209.
23. Guo J, Lemire BD (2003) The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide. J Biol Chem 278: 47629-47635.
24. Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, et al. (1998) A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394: 694-697.
25. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, et al. (2003) Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1 mice. Nat Genet 35: 331-340.
26. Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peczkowska M, et al. (2004) Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 74: 153-159.
27. Douwes Dekker PB, Hogendoorn PC, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, et al. (2003) SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J Pathol 201: 480-486.
28. Schadt EE, Li C, Ellis B, Wong WH (2001) Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl S37: 120-125.
29. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868.
30. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
31. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
32. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.
33. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
34. Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, et al. (2005) An oncogenic KRAS2 expression signature identified by cross-species geneexpression analysis. Nat Genet 37: 48-55.
35. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, et al. (2003) Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115: 629-640.
36. Semenza G (2002) Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64: 993-998.
37. Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, et al. (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet 32: 934-937.
38. Aguiar RC, Cox G, Pomeroy SL, Dahia PL (2001) Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. J Clin Endocrinol Metab 86: 2890-2894.
39. Dahia PLM, Aguiar RCT, Alberta J, Kum JB, Caron S, et al. (1999) PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet 8: 185-193.
40. Powers JF, Evinger MJ, Tsokas P, Bedri S, Alroy J, et al. (2000) Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 302: 309-320.
41. Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia-inducible factora and von Hippel-Lindau protein by direct binding to hypoxia-inducible factora. J Biol Chem 278: 15911-15916.
42. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Independent function of two destruction domains in hypoxia-inducible factora chains activated by prolyl hydroxylation. EMBO J 20: 5197-5206.
43. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. (2005) Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501.